Skip to main content
Fig. 6 | Cell & Bioscience

Fig. 6

From: Current insights into the implications of m6A RNA methylation and autophagy interaction in human diseases

Fig. 6

Effects of m6A-autophagy interaction in cancer drug resistance. A NSCLC could develop gefitinib resistance through m6A mediated activation of autophagy. B HCC could develop sorafenib resistance through m6A mediated decreased expression of FOXO3, which contributes to activation of autophagy. C Defective autophagy and m6A mediated increased stability of ARHGAP5 transcripts could promote chemoresistance in gastric cancer cells

Back to article page

Cell & Bioscience

ISSN: 2045-3701

Contact us